
Glycolysis M 0.5mg/500mg Tablet
Marketer
Jrb Lifesciences Private Limited
Salt Composition
Glimepiride (0.5mg) + Metformin (500mg)
Overview Glycolysis M 0.5mg/500mg Tablet
Diabetica Duo 0.5mg/500mg tablets are classified as antidiabetic medications, combining two active components for adult type 2 diabetes management. This formulation aids in regulating blood glucose. Diabetica Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counteract this. Alcohol consumption should be minimized due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood sugar monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your healthcare provider.
Uses of Glycolysis M 0.5mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Glycolysis M 0.5mg/500mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycolysis M 0.5mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Glycolysis M 0.5mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glycolysis M 0.5mg/500mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glycolysis M 0.5mg/500mg tablets with a meal.
How Glycolysis M 0.5mg/500mg Tablet works:
Glycolysis M tablets (0.5mg glimepiride/500mg metformin) combine the actions of two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glycolysis M 0.5mg/500mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Glycolysis M 0.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential risks prior to prescribing this medication. Seek medical advice.
Breast feedingUNSAFE
The 0.5mg/500mg Glycolysis M tablet is contraindicated for breastfeeding mothers due to potential infant toxicity.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glycolysis M 0.5mg/500mg tablets cautiously, potentially requiring dose modification. Physician consultation is necessary. Glycolysis M 0.5mg/500mg tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glycolysis M 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, this medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glycolysis M 0.5mg/500mg Tablet :
Should you forget to take your Glycolysis M 0.5mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glycolysis M 0.5mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
